Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanmeng Yu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Virology|March 6, 2015
Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate CancerNanmeng Yu, Shelby Puckett, Peter A Antinozzi, et al.
Journal of Immunotherapy and Precision Oncology|September 2, 2024
Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical SettingPrajwal Dhakal, Mario Sy, Grerk Sutamtewagul, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Quantifying PD1 saturation by PDL1 in tumor tissue using a novel RNA aptamer-based assaySuresh Veeramani, Chaobo Yin, Nanmeng Yu, et al.
International Journal of Molecular Sciences|June 26, 2026
Quantifying PD1 Saturation by PDL1 in Tumor Tissue Using a Novel RNA Aptamer-Based AssaySuresh Veeramani, Chaobo Yin, Nanmeng Yu, et al.
Translational Lung Cancer Research|September 29, 2021
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a <i>STK11</i> mutationJosiah An, Melissa Yan, Nanmeng Yu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Virology|March 6, 2015
Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate CancerNanmeng Yu, Shelby Puckett, Peter A Antinozzi, et al.
Journal of Immunotherapy and Precision Oncology|September 2, 2024
Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical SettingPrajwal Dhakal, Mario Sy, Grerk Sutamtewagul, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Quantifying PD1 saturation by PDL1 in tumor tissue using a novel RNA aptamer-based assaySuresh Veeramani, Chaobo Yin, Nanmeng Yu, et al.
International Journal of Molecular Sciences|June 26, 2026
Quantifying PD1 Saturation by PDL1 in Tumor Tissue Using a Novel RNA Aptamer-Based AssaySuresh Veeramani, Chaobo Yin, Nanmeng Yu, et al.
Translational Lung Cancer Research|September 29, 2021
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a <i>STK11</i> mutationJosiah An, Melissa Yan, Nanmeng Yu, et al.
Pageof 1